NCT02903420View on ClinicalTrials.gov

A Clinical Trial of Transcatheter Aortic Valves in Dialysis Patients (Japan)

NAActive, not recruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

February 14, 2019

Study Completion Date

January 31, 2026

Conditions
Aortic Stenosis
Interventions
DEVICE

Transcatheter Aortic Valve Implantation (TAVI)

Implantation of Edwards SAPIEN 3 Transcatheter Heart Valve (Model: 9600TFX) via transfemoral, transapical or transaortic approach.

Trial Locations (2)

565-0871

Osaka University Hospital, Suita

160-8582

Keio University Hospital, Shinjuku-Ku

Sponsors
All Listed Sponsors
lead

Edwards Lifesciences

INDUSTRY